Merit醫療系統 MMSI 深 滬
已收盤 12-12 16:00:00 美东时间
86.70
+0.170
+0.20%
華盛通- 最 高86.92
- 今 開86.72
- 成交量 59.24万股
- 最 低 85.87
- 昨 收 86.53
- 總市值 51.34亿
- 52周最高 111.45
- 市盈率 靜 42.76
- 換手率 1.00%
- 52周最低 78.116
- 委 比 82.54%
- 總股本 5921.91万
- 歷史最高 111.45
- 量 比 0.90
- 振 幅 1.21%
- 歷史最低 9.15
- 每 手 1
- 風險率 8.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Is the Market Bullish or Bearish on Merit Medical Systems Inc?
Merit Medical Systems Inc's (NYSE:MMSI) short interest as a percent of float ha...
12-12 21:00
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $106 Price Target
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and maintains $106 price target.
11-15 04:29
Merit Medical Systems Begins WRAPSODY CIE Commercialization
An announcement from Merit Medical Systems ( ($MMSI) ) is now available. Merit ...
11-14 06:51
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
Merit Medical Systems announced that the U.S. CMS has deferred its application for transitional pass-through incremental payment for WRAPSODY® CIE procedures until 2027. CEO Martha Aronson stated that while disappointed, this presents an opportunity for a strategic pivot, focusing on patient access, adoption, and utilization of their technology. WRAPSODY® CIE received FDA and Health Canada approval in 2024 and 2025, respectively, and is available...
11-13 21:05
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
Where Merit Medical Systems Stands With Analysts
In the latest quarter, 4 analysts provided ratings for Merit Medical Systems (N...
10-31 19:44
Merit Medical Systems shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 guidance above estimates.
Merit Medical Systems shares are trading higher after the company reported bett...
10-31 04:39
Earnings Scheduled For October 30, 2025
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Merit Medical’s Innovative Approach: Surfacer System Study Update
Merit Medical (($MMSI)) announced an update on their ongoing clinical study. St...
10-28 03:29
